1. Home
  2. NRSN vs CVR Comparison

NRSN vs CVR Comparison

Compare NRSN & CVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRSN
  • CVR
  • Stock Information
  • Founded
  • NRSN 2017
  • CVR 1920
  • Country
  • NRSN Israel
  • CVR United States
  • Employees
  • NRSN N/A
  • CVR N/A
  • Industry
  • NRSN Biotechnology: Pharmaceutical Preparations
  • CVR Industrial Machinery/Components
  • Sector
  • NRSN Health Care
  • CVR Industrials
  • Exchange
  • NRSN Nasdaq
  • CVR Nasdaq
  • Market Cap
  • NRSN 17.8M
  • CVR 16.0M
  • IPO Year
  • NRSN 2021
  • CVR N/A
  • Fundamental
  • Price
  • NRSN $1.14
  • CVR $16.04
  • Analyst Decision
  • NRSN Hold
  • CVR
  • Analyst Count
  • NRSN 1
  • CVR 0
  • Target Price
  • NRSN N/A
  • CVR N/A
  • AVG Volume (30 Days)
  • NRSN 360.5K
  • CVR 3.6K
  • Earning Date
  • NRSN 12-31-2024
  • CVR 11-12-2024
  • Dividend Yield
  • NRSN N/A
  • CVR 1.91%
  • EPS Growth
  • NRSN N/A
  • CVR N/A
  • EPS
  • NRSN N/A
  • CVR N/A
  • Revenue
  • NRSN N/A
  • CVR $29,663,473.00
  • Revenue This Year
  • NRSN N/A
  • CVR N/A
  • Revenue Next Year
  • NRSN N/A
  • CVR N/A
  • P/E Ratio
  • NRSN N/A
  • CVR N/A
  • Revenue Growth
  • NRSN N/A
  • CVR N/A
  • 52 Week Low
  • NRSN $0.51
  • CVR $13.81
  • 52 Week High
  • NRSN $2.33
  • CVR $22.27
  • Technical
  • Relative Strength Index (RSI)
  • NRSN 56.63
  • CVR 47.67
  • Support Level
  • NRSN $0.80
  • CVR $15.56
  • Resistance Level
  • NRSN $1.29
  • CVR $16.70
  • Average True Range (ATR)
  • NRSN 0.13
  • CVR 0.62
  • MACD
  • NRSN 0.01
  • CVR 0.03
  • Stochastic Oscillator
  • NRSN 68.75
  • CVR 59.77

About NRSN NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.

About CVR Chicago Rivet & Machine Co.

Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment. Geographically, the majority is from the United States.

Share on Social Networks: